Professional Documents
Culture Documents
DERMATOFITOSIS PPT (Usbah, Clau, Opi)
DERMATOFITOSIS PPT (Usbah, Clau, Opi)
DERMATOPHYTOSIS
CREATED BY :
CLAUDIA S.P KOTA SIKU 13 17 777 14 219
NOVIA PUTRI RAHMAN 13 17 777 14 222
USBAHUDDIN ALIMIN 13 17 777 14 239
Supervisor:
dr. Sukma Anjayani, M.Kes, Sp.KK
Palu, 21/01/2019
DEFINITION OF
DERMATOPHYTOSIS
Dermatophytosis is superfisial fungal infection that
affects skin, hair and nails which cause by Dermatophytoses
epidermophyton, Micosporum and Trichiphyton.
Schieke S.M, Garg A,. Dermatology in General Medicine. Ed 8. United States of America: McGraw
Hill; 2012.
CLASSIFICATION
A Tinea capitis describes dermatophyte
infection of hair and scalp
C
Tinea barbae affects the face unilaterally
and involves the beard area moore often
than the moustache or upper lip.
Verma S, Heffernan M.P.,Superficial Fungal Infections ; Dermatophytosis,Onychomycosis, Tinea Nigra, Piedra, In: Fitzpatrick's
T. Dermatology in General Medicine. Ed 7. United States of America: McGraw Hill; 2008. p:1807-20.
Schieke S.M, Garg A.,Superficial Fungal Infections, In: Fitzpatrick's T. Dermatology in General Medicine. Ed 8. United States of
America: McGraw Hill; 2012. p:2277-96.
Tinea corporis refers to any
D
dermatophytosis of glabrous skin except
palms, soles, and the groin.
Verma S, Heffernan M.P.,Superficial Fungal Infections ; Dermatophytosis,Onychomycosis, Tinea Nigra, Piedra, In: Fitzpatrick's T.
Dermatology in General Medicine. Ed 7. United States of America: McGraw Hill; 2008. p:1807-20.
Schieke S.M, Garg A.,Superficial Fungal Infections, In: Fitzpatrick's T. Dermatology in General Medicine. Ed 8. United States of
America: McGraw Hill; 2012. p:2277-96.
G
Onychomycosis describes fungal infection
of the nail caused by dermatophytes,
nondermatophyte molds, or yeasts. .
H
Tinea nigra is a superficial dermatomycosis
caused by dermatiaceous, darkly
pigmented.
Verma S, Heffernan M.P.,Superficial Fungal Infections ; Dermatophytosis,Onychomycosis, Tinea Nigra, Piedra, In: Fitzpatrick's T.
Dermatology in General Medicine. Ed 7. United States of America: McGraw Hill; 2008. p:1807-20.
Schieke S.M, Garg A.,Superficial Fungal Infections, In: Fitzpatrick's T. Dermatology in General Medicine. Ed 8. United States of
America: McGraw Hill; 2012. p:2277-96.
PATHOGENESIS
Dermatophytes can survive solely on outer cornified layers of
the skin. The ability of certain fungi to adhere to particular host arises
from numerous mechanisms and host factors, including the ability to
adapt to the human body. Natural infection is acquired by the
deposition of viable arthrospores or hyphae on the surface of the
susceptible individual. After the inoculation in the host skin, suitable
conditions favor the infection to progress through the stages of
adherence and penetration.
Marie-Pierre Hayette, Sacheli R., Dermatophytosis, Trends in Epidemiology and Diagnostic Approach. National Reference Center
for Mycosis article. Department of Clinical Microbiology, University Hospital of Liège, Belgium. 2015.
Rudramurthy S.M, Shaw D., Overview and update on the laboratory diagnosis of dermatophytosis. Clinical Dermatology
Review.Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. 2017;
Vol 1(3)p:1-3
METABOLISM OF
ERGOSTEROL IN FUNGI
1. Sertaconazole
Dosage : 2% sertaconazole cream is applied once or twice daily for a period of 4 weeks.
2. Ketokonazole
Dosage : 2% ketokonazole cream is applied once daily for a period of 2-4 weeks, 2%
ketokonazole shampoo recommendid 2-4 times weekly for 2-4 weeks.
4. Econazole
Dosage : 1% econazole cream is applied twice daily for a period of 2-4 weeks.
6. Oxiconazole
Indicated : Dermatophytosis.
Preparation : Cream.
8. Sulconazole
Indicated : Dermatophytosis.
1. Naftifine
Dosage : 2% naftivine cream and gel is applied once daily for a period of 2
weeks.
Indicated : Dermatophytosis.
Preparation : Cream.
3. Terbinafine
Indicated : Dermatophytosis.
1. Amorolphyne
1. Siclopirox Olamine
•Schieke S.M, Garg A.,Superficial Fungal Infections, In: Fitzpatrick's T. Dermatology in General Medicine. Ed 8. United States of America:
McGraw Hill; 2012. p:2277-96.
•Hay R.J, Ashbee H.R.,Mycology. Rook’s Book. Text Book of Dermatology. Ed 8.Garsington, Oxford, Untited State of America: Wiley-
Balck Well. 2010. Chapter 36.36-36.48
•Setiabudy R, Gunawan SG, Nafrialdi, Instiaty. Obat Jamur. Farmakologi dan Terapi. Badan Penerbit Fakultas Kedokteran Universitas
Indonesia. Ed 6. Jakarta. 2016. p.5
GRISEOVULFIN
This is a metabolic product derived from species of
Penicillium. Its activity, which is fungistatic, is largerly
restricted to dermatophyte infections. The mode of actio
appears to be in part through inhibition of the formation of
intracelullar microtubules.
• Dossage
Adults
Children
Tinea capitis : 20 - 25 mg/kg/day to 6 – 8
• Tinea corporis/cruris :
weeks
10 - 20mg/kg/day to 2- 4
Tinea barbae : 1gr/kg/day to 6 weeks
weeks
Tinea corporis/cruris : 500mg/day to 2 – 4
weeks
• Dossage :
Adults Children
200 – 400mg/day, for tinea corporis and • Tinea corporis/cruris :
cruris can use for 2 – 4 weeks 10 - 20mg/kg/day to 2- 4
Cant recommended for tinea capitis and weeks
onychomycosis
Side effects : common side effects include anorexia, vomite, and nausea.
• Dossage :
Adults
Tinea capitis : 6 mg/kg/day to 3 weeks
Children
Tinea barbae : 200mg/day to 4 – 6 weeks
• Onychomycosis :
Tinea corporis/cruris : 150 – 300mg/day to
6mg/kg/week to 3 – 6
4 – 6 weeks
months
Tinea Pedis : 150mg/week to 3 – 4 weeks
Onychomycosis : 150 – 300mg/week to 3 –
12 months
• Dossage :
Adults
Tinea capitis : 250mg/day to 2 – 8 weeks
Tinea barbae : 250mg/day to 2 – 4 weeks
Tinea corporis/cruris : 250mg/day to 2 – 4 weeks
Tinea Pedis : 250mg/week to 2 weeks
Onychomycosis : 250mg/week to 6 – 12 weeks
Children
Tinea capitis : 3 – 6mg/kg/day to 2 – 8 weeks
Tinea corporis/cruris : 3 – 6mg/kg/day to 2 weeks
Tinea pedis : 3 – 6mg/kg/day to 2 weeks
Onychomycosis : 3 – 6mg/kg/day to 6 – 12 weeks
THANKYOU